Keeping with yesterday's discussion of Patent Trial & Appeal Board (PTAB) estoppel in the district courts, a decision from earlier this year on yet another aspect of this estoppel has been recalibrated.
District courts continue to grapple with whether or not physical products described by prior art publications of an earlier Patent Trial & Appeal Board (PTAB) trial are subject to estoppel.
With
Thomas N. Bulleit,
Matthew Rizzolo
That really ties the hands of plans trying to get lower prices because they can't exclude similar drugs just because they're expensive.
The Patent Trial and Appeal Board (PTAB) will host a Boardside Chat webinar this Thursday, August 22, from noon to 1 p.m. ET
As discussed some months back, the PTAB new POP decided its first case in Proppant Express Investments v. Oren Technologies, Case IPR2018-00914.
The Federal Circuit's en banc opinion in In re Aqua Products was as massive as it was unfulfilling.
The Patent Trial & Appeal Board (PTAB) has been steadily rolling out new precedent since establishing it Precedential Opinion Panel (POP).
The USPTO will host a Boardside Chat webinar on Thursday, August 8, from noon to 1PM (EST) to address recent updates made to the AIA Trial Practice
Since the Supreme Court's decision in Cuozzo Speed, there has been speculation that there may be an opportunity to attack AIA
A perceived lack of Article III standing in appeals from the Patent Trial & Appeal Board (PTAB) to the Federal Circuit can doom an appeal.
Longest Running PTAB Program in NYC 9/11/19
The 2019 update mostly revises sections of the Guide that have been outdated since the initial 2012 printing.
The USPTO is hosting a Boardside Chat webinar on Thursday, July 18, from noon to 1 p.m. ET, to discuss its previous PTAB Orange Book patent/biologic patent study
The Stronger Patents Act just wont go away. While the bill has been introduced several times over the years
Non-precedential Decision Faults Long-Standing PTAB Practice
Based on Mondaq users readership, this author is ranked as Very Popular in United States for the topics, user groups and industry sectors listed below:
Topics
Sovereign Immunity: Public Sector GovernmentIndustry
PropertyNot For ProfitEngineering, ConstructionOil & Gas* Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.
